Game Plan Financial Advisors’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25
| Closed | -$44 | – | 383 |
|
|
2025
Q1 | $44 | Hold |
25
| – | – | ﹤0.01% | 349 |
|
|
2024
Q4 | $56 | Hold |
25
| – | – | ﹤0.01% | 361 |
|
|
2024
Q3 | $89 | Hold |
25
| – | – | ﹤0.01% | 373 |
|
|
2024
Q2 | $69 | Sell |
25
-25
| -50% | -$69 | ﹤0.01% | 366 |
|
|
2024
Q1 | $332 | Hold |
50
| – | – | ﹤0.01% | 399 |
|
|
2023
Q4 | $152 | Buy |
+50
| New | +$152 | ﹤0.01% | 423 |
|
|
2022
Q4 | – | Sell |
-5,000
| Closed | -$21K | – | 103 |
|
|
2022
Q3 | $21K | Sell |
5,000
-150
| -3% | -$630 | 0.02% | 84 |
|
|
2022
Q2 | $27K | Buy |
5,150
+500
| +11% | +$2.62K | 0.02% | 90 |
|
|
2022
Q1 | $48K | Buy |
4,650
+250
| +6% | +$2.58K | 0.03% | 98 |
|
|
2021
Q4 | $50K | Sell |
4,400
-1,950
| -31% | -$22.2K | 0.03% | 102 |
|
|
2021
Q3 | $130K | Buy |
6,350
+1,350
| +27% | +$27.6K | 0.08% | 93 |
|
|
2021
Q2 | $125K | Buy |
5,000
+1,125
| +29% | +$28.1K | 0.07% | 95 |
|
|
2021
Q1 | $112K | Buy |
3,875
+450
| +13% | +$13K | 0.07% | 92 |
|
|
2020
Q4 | $71K | Buy |
+3,425
| New | +$71K | 0.05% | 88 |
|
|
2020
Q3 | – | Sell |
-3,170
| Closed | -$75K | – | 76 |
|
|
2020
Q2 | $75K | Buy |
3,170
+75
| +2% | +$1.77K | 0.11% | 52 |
|
|
2020
Q1 | $20K | Buy |
3,095
+600
| +24% | +$3.88K | 0.02% | 83 |
|
|
2019
Q4 | $29K | Buy |
+2,495
| New | +$29K | 0.03% | 93 |
|